Ticker brief
EYPT
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
4
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.35 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @KASM_Capital | C | · | 3 | +0.15 |
| @semodough | C | -0.75 | 3 | +0.47 |
| @Quantumup1 | C | -1.95 | 1 | +0.00 |
| @adamfeuerstein | A | +1.05 | 1 | +0.00 |
Recent signals8of 8 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @semodough | +0.35 | Cites Chardan arguing DURAVYU sham masking is not disqualifying for FDA efficacy control. | · | tweet ↗ |
| 2026-07-01 | @semodough | +0.40 | Chardan raises EYPT price target to $65 from $29. | · | tweet ↗ |
| 2026-06-30 | @KASM_Capital | -0.50 | Dismissive 'enjoy your retirement' comment toward EYPT. | · | tweet ↗ |
| 2026-06-24 | @semodough | +0.65 | Guggenheim top pick expects positive LUGANO and LUCIA data and multi-blockbuster potential. | · | tweet ↗ |
| 2026-06-24 | @adamfeuerstein | +0.00 | Asks whether another drug is better than OCUL and EYPT drugs; stance unclear. | · | tweet ↗ |
| 2026-06-23 | @KASM_Capital | +0.40 | Mentions EYPT up 5% today while promoting flow alerts. | · | tweet ↗ |
| 2026-06-22 | @KASM_Capital | +0.55 | Says EYPT flow is the type you retire from, implying bullishness. | · | tweet ↗ |
| 2026-06-22 | @Quantumup1 | +0.00 | H.C. Wainwright reiterated OCUL Buy and raised PT to $25 from $21. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.